TipRanks
Agilent (A)
NYSE:A
US Market
A
Agilent
RESEARCH TOOLSreports
Want to see A full AI Analyst Report?

Agilent (A) Stock Forecast & Price Target

3,440 Followers
See the Price Targets and Ratings of:

A Analyst Ratings

Strong Buy
14Ratings
Strong Buy
11 Buy
3 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Agilent
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

A Stock 12 Month Forecast

Average Price Target

$183.14
▲(18.33% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is $183.14 with a high forecast of $196.00 and a low forecast of $150.00. The average price target represents a 18.33% change from the last price of $154.77.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"113":"$113","134":"$134","155":"$155","176":"$176","197":"$197"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":196,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$196.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":183.14285714285714,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$183.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$150.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[113,134,155,176,197],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,166.431,168.70553846153848,170.98007692307692,173.2546153846154,175.52915384615386,177.8036923076923,180.07823076923077,182.35276923076924,184.62730769230768,186.90184615384615,189.17638461538462,191.45092307692306,193.72546153846153,{"y":196,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,166.431,167.71652747252747,169.00205494505497,170.28758241758243,171.5731098901099,172.85863736263738,174.14416483516484,175.4296923076923,176.71521978021977,178.00074725274726,179.28627472527472,180.57180219780219,181.85732967032968,{"y":183.14285714285714,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,166.431,165.16707692307693,163.90315384615386,162.63923076923078,161.3753076923077,160.11138461538462,158.84746153846154,157.58353846153847,156.3196153846154,155.0556923076923,153.79176923076923,152.52784615384616,151.26392307692308,{"y":150,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":137.547,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.269,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.982,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.056,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.621,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.499,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.149,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.129,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.516,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.191,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.164,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.706,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.431,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$196.00Average Price Target$183.14Lowest Price Target$150.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on A
Doug Schenkel
UBS
UBS
$180
Hold
16.30%
Upside
Reiterated
10/14/26
UBS Remains a Hold on Agilent (A)
TD Cowen Analyst forecast on A
Daniel Brennan
TD Cowen
TD Cowen
$180→$196
Buy
26.64%
Upside
Reiterated
10/13/26
Agilent price target raised to $196 from $180 at TD CowenAgilent price target raised to $196 from $180 at TD Cowen
Morgan Stanley Analyst forecast on A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$175→$190
Buy
22.76%
Upside
Assigned
10/13/26
Agilent price target raised to $190 from $175 at Morgan StanleyAgilent price target raised to $190 from $175 at Morgan Stanley
Bank of America Securities Analyst forecast on A
Michael Ryskin
Bank of America Securities
Bank of America Securities
$180→$190
Buy
22.76%
Upside
Reiterated
10/13/26
Analysts' Top Healthcare Picks: Agilent (A), Guardant Health (GH)
Bernstein Analyst forecast on A
Eve Burstein
Bernstein
Bernstein
$180
Buy
16.30%
Upside
Reiterated
10/12/26
Agilent (A) Receives a Buy from Bernstein
Barclays Analyst forecast on A
Luke Sergott
Barclays
Barclays
$175→$195
Buy
25.99%
Upside
Reiterated
10/07/26
Barclays Sticks to Their Buy Rating for Agilent (A)
Goldman Sachs Analyst forecast on A
Evie Koslosky
Goldman Sachs
Goldman Sachs
$175→$185
Buy
19.53%
Upside
Reiterated
09/20/26
Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Ascendis Pharma (ASND)
Jefferies Analyst forecast on A
John Dunigan
Jefferies
Jefferies
$181
Hold
16.95%
Upside
Reiterated
09/17/26
Analysts Conflicted on These Healthcare Names: Agilent (NYSE: A) and Aquestive Therapeutics (NASDAQ: AQST)
Stifel Nicolaus Analyst forecast on A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$180
Buy
16.30%
Upside
Reiterated
08/30/26
Stifel Nicolaus Reaffirms Their Buy Rating on Agilent (A)
Piper Sandler Analyst forecast on A
David Westenberg
Piper Sandler
Piper Sandler
$150
Hold
-3.08%
Downside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
J.P. Morgan Analyst forecast on A
Casey Woodring
J.P. Morgan
J.P. Morgan
$180→$190
Buy
22.76%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Evercore ISI Analyst forecast on A
Vijay Kumar
Evercore ISI
Evercore ISI
$148→$172
Buy
11.13%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
Citi Analyst forecast on A
Patrick B Donnelly
Citi
Citi
$185→$190
Buy
22.76%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
RBC Capital Analyst forecast on A
Dan Leonard
RBC Capital
RBC Capital
$155→$185
Buy
19.53%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
HSBC Analyst forecast on A
Sidharth Sahoo
HSBC
HSBC
$180→$165
Buy
6.61%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on A
Doug Schenkel
UBS
UBS
$180
Hold
16.30%
Upside
Reiterated
10/14/26
UBS Remains a Hold on Agilent (A)
TD Cowen Analyst forecast on A
Daniel Brennan
TD Cowen
TD Cowen
$180→$196
Buy
26.64%
Upside
Reiterated
10/13/26
Agilent price target raised to $196 from $180 at TD CowenAgilent price target raised to $196 from $180 at TD Cowen
Morgan Stanley Analyst forecast on A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$175→$190
Buy
22.76%
Upside
Assigned
10/13/26
Agilent price target raised to $190 from $175 at Morgan StanleyAgilent price target raised to $190 from $175 at Morgan Stanley
Bank of America Securities Analyst forecast on A
Michael Ryskin
Bank of America Securities
Bank of America Securities
$180→$190
Buy
22.76%
Upside
Reiterated
10/13/26
Analysts' Top Healthcare Picks: Agilent (A), Guardant Health (GH)
Bernstein Analyst forecast on A
Eve Burstein
Bernstein
Bernstein
$180
Buy
16.30%
Upside
Reiterated
10/12/26
Agilent (A) Receives a Buy from Bernstein
Barclays Analyst forecast on A
Luke Sergott
Barclays
Barclays
$175→$195
Buy
25.99%
Upside
Reiterated
10/07/26
Barclays Sticks to Their Buy Rating for Agilent (A)
Goldman Sachs Analyst forecast on A
Evie Koslosky
Goldman Sachs
Goldman Sachs
$175→$185
Buy
19.53%
Upside
Reiterated
09/20/26
Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Ascendis Pharma (ASND)
Jefferies Analyst forecast on A
John Dunigan
Jefferies
Jefferies
$181
Hold
16.95%
Upside
Reiterated
09/17/26
Analysts Conflicted on These Healthcare Names: Agilent (NYSE: A) and Aquestive Therapeutics (NASDAQ: AQST)
Stifel Nicolaus Analyst forecast on A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$180
Buy
16.30%
Upside
Reiterated
08/30/26
Stifel Nicolaus Reaffirms Their Buy Rating on Agilent (A)
Piper Sandler Analyst forecast on A
David Westenberg
Piper Sandler
Piper Sandler
$150
Hold
-3.08%
Downside
Reiterated
08/27/26
Piper Sandler Sticks to Its Hold Rating for Agilent (A)
J.P. Morgan Analyst forecast on A
Casey Woodring
J.P. Morgan
J.P. Morgan
$180→$190
Buy
22.76%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $180 at JPMorganAgilent price target raised to $190 from $180 at JPMorgan
Evercore ISI Analyst forecast on A
Vijay Kumar
Evercore ISI
Evercore ISI
$148→$172
Buy
11.13%
Upside
Reiterated
08/27/26
Agilent price target raised to $172 from $148 at Evercore ISIAgilent price target raised to $172 from $148 at Evercore ISI
Citi Analyst forecast on A
Patrick B Donnelly
Citi
Citi
$185→$190
Buy
22.76%
Upside
Reiterated
08/27/26
Agilent price target raised to $190 from $185 at CitiAgilent price target raised to $190 from $185 at Citi
RBC Capital Analyst forecast on A
Dan Leonard
RBC Capital
RBC Capital
$155→$185
Buy
19.53%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
HSBC Analyst forecast on A
Sidharth Sahoo
HSBC
HSBC
$180→$165
Buy
6.61%
Upside
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
AXGNAxoGen
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
REPLReplimune Group
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

3 Months
Dan LeonardRBC Capital
Success Rate
19/28 ratings generated profit
68%
Average Return
+5.53%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +5.53% per trade.
1 Year
Dan LeonardRBC Capital
Success Rate
23/28 ratings generated profit
82%
Average Return
+25.32%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +25.32% per trade.
2 Years
Patrick B DonnellyCiti
Success Rate
18/21 ratings generated profit
86%
Average Return
+24.12%
Copying Patrick B Donnelly's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +24.12% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

A Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
2
2
1
0
0
Buy
15
15
20
21
25
Hold
2
3
4
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
20
25
28
32
In the current month, A has received 25 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. A average Analyst price target in the past 3 months is 183.14.
Each month's total comprises the sum of three months' worth of ratings.

A Financial Forecast

A Earnings Forecast

Next quarter’s earnings estimate for A is $1.73 with a range of $1.71 to $1.74. The previous quarter’s EPS was $1.62. A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.
Next quarter’s earnings estimate for A is $1.73 with a range of $1.71 to $1.74. The previous quarter’s EPS was $1.62. A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.

A Sales Forecast

Next quarter’s sales forecast for A is $1.99B with a range of $1.98B to $2.00B. The previous quarter’s sales results were $1.88B. A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.
Next quarter’s sales forecast for A is $1.99B with a range of $1.98B to $2.00B. The previous quarter’s sales results were $1.88B. A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.

A Stock Forecast FAQ

What is A’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent’s 12-month average price target is 183.14.
    What is A’s upside potential, based on the analysts’ average price target?
    Agilent has 18.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is A a Buy, Sell or Hold?
          Agilent has a consensus rating of Strong Buy which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Agilent’s price target?
            The average price target for Agilent is 183.14. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $196.00 ,the lowest forecast is $150.00. The average price target represents 18.33% Increase from the current price of $154.77.
              What do analysts say about Agilent?
              Agilent’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of A?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.